Jazz Pharmaceuticals
JAZZ
$133.73
Share price
1.43%
Change (1 day)
-11.82%
Change (1 year)
Categories
Operating Margin for Jazz Pharmaceuticals (JAZZ)
Operating Margin as of September 2023 (TTM): -6.99%
According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -6.99%. At the end of 2022 the company had an Operating Margin of -10.19%.
Operating Margin history for Jazz Pharmaceuticals from 2005 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -10.19% | 179.35% |
| 2021 | -3.65% | -131.33% |
| 2020 | 11.64% | -44.62% |
| 2019 | 21.02% | -24.95% |
| 2018 | 28.00% | 2.75% |
| 2017 | 27.25% | -23.84% |
| 2016 | 35.78% | 8.75% |
| 2015 | 32.91% | 154.65% |
| 2014 | 12.92% | -63.39% |
| 2013 | 35.30% | 16.63% |
| 2012 | 30.27% | -35.53% |
| 2011 | 46.95% | 41.18% |
| 2010 | 33.25% | 168.14% |
| 2009 | 12.40% | -105.96% |
| 2008 | -208.26% | -2% |
| 2007 | -212.51% | 22.13% |
| 2006 | -174.01% | -34.71% |
| 2005 | -266.50% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 17.27% | -347.07% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | 0.82% | -111.73% | 🇺🇸 USA |
 Endo International
ENDPQ | -129.15% | 1,747.64% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | -20.53% | 193.71% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.